Skip to content

lateral antebrachial cutaneous nerve block for percutaneous transluminal angioplasty of dysfunctional autologous arteriovenous fistula in forearm: A randomized controlled trial

lateral antebrachial cutaneous nerve block for percutaneous transluminal angioplasty of dysfunctional autologous arteriovenous fistula in forearm: A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101902
Enrollment
Unknown
Registered
2025-05-05
Start date
2025-05-05
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysfunctional autologous arteriovenous fistula in forearm

Interventions

Group of lateral antebrachial cutaneous nerve block:Lateral antebrachial cutaneous nerve block
Group of local infiltration anesthesia :Local infiltration anesthesia

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All adult patients (aged 18 years or older) undergoing PTA therapy for dysfunctional forearm AVF were eligible for inclusion

Exclusion criteria

Exclusion criteria: The exclusion criteria were as following: AVF stenotic lesion above antecubital crease, history of neurologic deficit in ipsilateral arm, allergy to local anesthetic, pregnancy.

Design outcomes

Primary

MeasureTime frame
Numeric rating pain score;

Countries

China

Contacts

Public Contactjiaojundong

The Second Affiliated Hospital of Harbin Medical University

jiaojundong@163.com+86 138 4500 6919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026